John David Finley - 11 Feb 2025 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role
CEO, CFO, Director
Signature
/s/ JD Finley
Issuer symbol
PALI
Transactions as of
11 Feb 2025
Net transactions value
$0
Form type
4
Filing time
13 Feb 2025, 17:56:42 UTC
Previous filing
30 May 2024
Next filing
05 Sep 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Stock Option (Right to Buy) Award $0 +47,000 $0.000000 47,000 11 Feb 2025 Common Stock 47,000 $1.13 Direct F1
transaction PALI Restricted Stock Units Award $0 +40,000 $0.000000 40,000 11 Feb 2025 Common Stock 40,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in twelve equal quarterly installments over a three-year period beginning on May 11, 2025, subject to the Reporting Person's continuous service through each such vesting date.
F2 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F3 The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service through each such vesting date.